The KEMRI Wellcome Trust Research Programme in partnership with the Pasteur Institute of Dakar (IPD) will be hosting a webinar on Market Access for Vaccines – Factors that influence personal choices.
Barbara Ngouyombo, Associate Director Partnerships at Institut Pasteur de Dakar with be the guest speaker for the webinar scheduled for the 7th of September 2023. This webinar will be presented in French. Interested in attending this webinar,
Register here. https://shorturl.at/dnxHU.
The Pasteur Institute of Dakar (IPD) is a Senegalese private foundation, non-profit and recognized as being of public utility. It is a member of the international network of Pasteur Institutes. Its objective is to “contribute to public health in Africa, particularly in Senegal, by conducting activities related to research, teaching, training, medical, epidemiological and biological expertise, and yellow fever vaccine production. The IPD stands out as a research hub serving African populations, particularly in addressing public health issues across the entire continent. Its expertise and innovative work radiate on an international scale.
The KEMRI Wellcome Trust Research Programme (KWTRP) is a world-renowned health research unit of excellence based in Kilifi and Nairobi in Kenya as well as Mbale in Uganda. Over the years, KWTRP has excelled in the use of novel ideas, and collaborations to achieve better health for Africa while also developing African scientific leaders.
The KWTRP Vaccinology Workforce Development (KWTRP_WFD) is a programme that seeks to expand the technical know-how and capability for sustainable end-to-end vaccine research and development in Africa through collaborative training and knowledge exchange activities. The programme scope covers the vaccine ecosystem including target product profiling, discovery, biomanufacturing processes, quality assurance, pre-clinical and clinical studies, regulatory affairs, and deployment.